Search database
LIST OPTIONS
Filter
23
Filtered Results: 23
Text search: European & Developing Countries Clinical Trials Partnership EDCTTP
Featured
Language
Document type
Studies & Reports
9
No document type
7
Fact sheets
3
Strategic & Response Plan
2
Guidelines
1
Infographics
1
Countries / Regions
Global
3
Mozambique
2
West and Central Africa
2
East and Southern Africa
2
Kenya
1
Burkina Faso
1
Middle East and North Africa
1
Ethiopia
1
Authors & Publishers
World Health Organization WHO
3
Africa CDC Centres for Disease Control and Prevention
1
African Union
1
Amterdam Institute for Global health & Development aighd
1
and S. Mauder
1
BUKO Pharma-Kampagne/Gesundheit und Dritte Welt e.V.
1
Coalition for Epidemic Preparedness Innovations (CEPI)
1
Cochrane Convenes
1
Coulibaly M., N. Meda, C. Yonaba et al.
1
DNDi - Drugs for neglected diseases initiative
1
Drugs for Neglected Diseases initiative DNDi
1
European & Developing Countries Clinical Trials Partnership EDCTTP
1
Evangelina IN, Inês T, Miguelhete L et al
1
FOCUS
1
G-Finder
1
International Vaccines Task Force (IVTF)
1
LEAP
1
Lindner A. K.
1
PLOS ONE
1
ReAct Action on Antibiotic Resistance
1
Reijer, P.
1
Rupérez et al.
1
S. Ali, A. Haileamlak, A. Wieser, et al.
1
S. H. E. Kaufmann, T. G. Evans, W. A. Hanekom
1
Schistosomiasis Pediatric Praziquanel Consortium
1
V. Lejon, M.P. Barrett, et al.
1
World Health Organisation (WHO)
1
Publication Years
Category
Countries
5
Key Resources
2
Toolboxes
TB
6
NTDs
5
Health Financing Toolbox
3
COVID-19
2
AMR
2
Rapid Response
1
Global Health Education
1
 Download  (274)
  View PDF  (373)
 Add to my MEDBOX

Use of alternative interferon-gamma release assays for the diagnosis of TB infection: WHO policy statement

World Health Organization WHO (2022) C_WHO
Following review of evidence and advice from the Technical Advisory Group (TAG) on Tuberculosis (TB) Diagnostics and Laboratory Strengthening, the World Health Organization (WHO) announces that current WHO recommendations for the use of interferon-gamma release assays (IGRA) are also valid for Beij... more
 Download  (346)
  View PDF  (590)
 Add to my MEDBOX

Leitfaden für sozialverträgliche Verwertung: Forschungsergebnisse für möglichst viele Menschen nutzbar machen

BUKO Pharma-KampagneGesundheit und Dritte Welt e.V. (2018) CC
Diese Broschüre möchte dazu beitragen, dass möglichst viele Menschen die Ergebnisse öffentlich finanzierter Forschung nutzen können.
 Download  (115)
  View PDF  (175)
 Add to my MEDBOX

New WHO guidelines for treating rhodesiense human African trypanosomiasis: expanded indications for fexinidazole and pentamidine
recommended

Lindner A. K.; V. Lejon, M.P. Barrett, et al. (2025) CC
The Lancet Infectious Disease Volume 25, Issue 2e77-e85February 2025